Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Recurrent breast cancer
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Patterns''' == * Local recurrence ** True recurrence - at lumpectomy site ** Marginal miss - recurrence close to but not within the boost volume ** Elsewhere recurrence - different quadrant to original procedure * Regional recurrence - draining lymph nodes - axillary, infraclavicular, supraclavicular, internal mammary * Metastatic disease == '''Predicting recurrence''' == * See entry under 'breast cancer' == '''Scenarios''' == * '''Ipsilateral breast tumour recurrence after breast-conserving therapy''' ** Assuming metastasis has been excluded, mastectomy is standard of care. Repeat lumpectomy is associated with higher recurrence rates, especially if it's been <5 years since original cancer. If it's later than 5 years, likely to be a different primary cancer. ** About 10-20% are inoperable for whatever reason ** If regional spread is present, may need neoadjuvant CTX ** Generally standard mastectomy with delayed reconstruction is necessary, due to previous radiation. Autologous tissue flaps (DIEP/TRAM) is often required. ** Ability to perform nodal staging is dependent on original operation * '''Local recurrence after mastectomy''' ** Uncommon ** Assess feasibility of resection with examination, USS, MRI, CT - may require WLE of ribs or chest wall etc ** Consider neoadjuvant CTX * '''Lymph node recurrence''' ** Incidence is about 1% in those who had ALND, and less than that if they had a negative SLNB originally ** Workup: *** Full systemic staging (CT BCAP + bone scan/PET) *** Core biopsy of axillary disease to confirm same molecular profile to original tumour ** Treatment: *** If they were previously SLNB negative or never had an ALND, they should have an ALND *** If they already had an ALND, they should have a redo/completion ALND to level III, or radiotherapy to axilla *** Adjuvant systemic therapy if not contraindicated ** Prognosis: 60% overall survival at 5 years, 45% at 10 years [[Category:Breast]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Recurrent breast cancer
Add topic